Latest news with #SMSPharmaceuticals
Business Upturn
13 hours ago
- Business
- Business Upturn
SMS Pharmaceuticals clears second USFDA inspection at Hyderabad lab with zero observations
By Aman Shukla Published on June 25, 2025, 16:19 IST SMS Pharmaceuticals has recently informed exchanges that the company successfully completed its second inspection by the United States Food and Drug Administration (USFDA) at its Central Laboratory Analytical Services in Gagillapur, Hyderabad. The inspection, held from June 23 to June 25, 2025, concluded with zero Form 483 observations, reflecting the company's strong focus on quality and compliance. This Central Lab is an independent analytical testing facility, and the clean inspection outcome reaffirms SMS Pharma's commitment to CGMP and GLP standards across all its units. The company continues to maintain world-class quality practices, ensuring trust and reliability in every aspect of its operations. In the meantime, SMS Pharmaceuticals shares closed today at ₹239.00, after opening at ₹234.25. The stock touched an intraday high of ₹239.90 and a low of ₹234.25 during the session. The company's 52-week high stands at ₹398.00, while the 52-week low is ₹176.05. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Standard
02-05-2025
- Business
- Business Standard
SMS Pharmaceuticals' Unit VII receives WHO Geneva prequalification
SMS Pharmaceuticals announced that Unit VII manufacturing facility in Visakhapatnam, Andhra Pradesh, has received prequalification approval from the World Health Organisation (WHO) Geneva. The company added, "This significant milestone enhances our global regulatory standing and enables the company to increase its presence in the global market for Anti-Retroviral (ARV) APIs." Commenting on this achievement, P. Vamsi Krishna, Executive Director, stated: The WHO Geneva prequalification reflects the company's strong compliance with stringent international regulatory standards, reinforcing its reputation for quality, reliability, and global competitiveness."
